UM  > 健康科學學院
Bayesian adaptive determination of the sample size required to assure acceptably low adverse event risk
Lawrence Gould A.; Zhang X.D.
2014-03-15
Source PublicationStatistics in Medicine
ISSN02776715 10970258
Volume33Issue:6Pages:940-957
AbstractAn emerging concern with new therapeutic agents, especially treatments for type 2 diabetes, a prevalent condition that increases an individual's risk of heart attack or stroke, is the likelihood of adverse events, especially cardiovascular events, that the new agents may cause. These concerns have led to regulatory requirements for demonstrating that a new agent increases the risk of an adverse event relative to a control by no more than, say, 30% or 80% with high (e.g., 97.5%) confidence. We describe a Bayesian adaptive procedure for determining if the sample size for a development program needs to be increased and, if necessary, by how much, to provide the required assurance of limited risk. The decision is based on the predictive likelihood of a sufficiently high posterior probability that the relative risk is no more than a specified bound. Allowance can be made for between-center as well as within-center variability to accommodate large-scale developmental programs, and design alternatives (e.g., many small centers, few large centers) for obtaining additional data if needed can be explored. Binomial or Poisson likelihoods can be used, and center-level covariates can be accommodated. The predictive likelihoods are explored under various conditions to assess the statistical properties of the method. © 2013 John Wiley & Sons, Ltd.
KeywordAdaptive design Predictive distribution Relative risk Robustness Sensitivity
DOI10.1002/sim.5993
URLView the original
Language英語
全文获取链接
引用统计
Document TypeJournal article
专题Faculty of Health Sciences
AffiliationMerck Research Laboratories
推荐引用方式
GB/T 7714
Lawrence Gould A.,Zhang X.D.. Bayesian adaptive determination of the sample size required to assure acceptably low adverse event risk[J]. Statistics in Medicine,2014,33(6):940-957.
APA Lawrence Gould A.,&Zhang X.D..(2014).Bayesian adaptive determination of the sample size required to assure acceptably low adverse event risk.Statistics in Medicine,33(6),940-957.
MLA Lawrence Gould A.,et al."Bayesian adaptive determination of the sample size required to assure acceptably low adverse event risk".Statistics in Medicine 33.6(2014):940-957.
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
Google Scholar
中相似的文章 Google Scholar
[Lawrence Gould A.]的文章
[Zhang X.D.]的文章
Baidu academic
中相似的文章 Baidu academic
[Lawrence Gould A.]的文章
[Zhang X.D.]的文章
Bing Scholar
中相似的文章 Bing Scholar
[Lawrence Gould A.]的文章
[Zhang X.D.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。